Crohn’s Disease
(Study 1)
Receive compensation up to $2,300.00 for participation
Qualified Participants:
- Male & Female Participants ages 16 to 80 years old
- Moderately to severe Crohn’s disease
- Inadequate response or intolerance to intervention with oral amino salicylates, oral CS, azathioprine, methotrexate, or 6-mercaptopurine, or demonstrated CS dependence for the treatment of CD
Now at the following sites: Uniontown
Moderate to Severe Crohn’s Treatment
Receive compensation for participation
Qualified Participants:
- Male & Female Participants ages 18 and older
- Have Crohn’s disease or fistulizing Crohn’s disease of at least 3 months duration with colitis, ileitis, or ileocolitis, confirmed at any time in the past by radiography, histology, and/or endoscopy.
- Have moderate to Severe Crohn’s Disease
Now at the following sites: Uniontown, PA.
Moderate to Severe Crohn’s Treatment
Receive compensation participation
Qualified Participants:
- Male & Female Participants ages 18 and older
- Have Crohn’s disease or fistulizing Crohn’s disease of at least 3 months duration with colitis, ileitis, or ileocolitis, confirmed at any time in the past by radiography, histology, and/or endoscopy.
- Have moderate to Severe Crohn’s Disease
Now at the following sites: Uniontown
Registry Study
Receive compensation for participation
Qualified Participants:
- Male & Female Participants ages 18 and older
- Diagnosis of Crohn’s Disease established within five years
Now at the following sites: Uniontown, PA.
